The halo effect of the pandemic is waning as consumer trust declines in our industry.
A recent Harris Poll indicated that, at the height of the pandemic (Feb 2021), 62 percent of the public held a favorable view of the pharmaceutical industry, higher than any other point in history.
One year later, trust for the pharmaceutical industry has dropped 15 percent, and could continue to plunge.
How can your company maintain that trust and prevent it from slipping further?
Download the full PDF to learn more about the top reputation & business risk factors for life science and healthcare companies in 2022.